AAAAAA

   
Results: 1-16 |
Results: 16
Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas
Authors: Yutani, S Shichijo, S Inoue, Y Kawagoe, N Okuda, K Kurohiji, T Tanaka, M Sata, M Itoh, K
Citation: S. Yutani et al., Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas, ONCOL REP, 8(2), 2001, pp. 369-372
Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes
Authors: Tamura, M Nishizaka, S Maeda, Y Ito, M Harashima, N Harada, M Shichijo, S Itoh, K
Citation: M. Tamura et al., Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes, JPN J CANC, 92(7), 2001, pp. 762-767
Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation
Authors: Harada, K Yamada, A Yang, DM Itoh, K Shichijo, S
Citation: K. Harada et al., Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation, INT J CANC, 93(5), 2001, pp. 623-628
Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases
Authors: Harashima, N Tanaka, K Sasatomi, T Shimizu, K Miyagi, Y Yamada, A Tamura, M Yamana, H Itoh, K Shichijo, S
Citation: N. Harashima et al., Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases, EUR J IMMUN, 31(2), 2001, pp. 323-332
Molecular basis of T cell-mediated recognition of pancreatic cancer cells
Authors: Ito, M Shichijo, S Tsuda, N Ochi, M Harashima, N Saito, N Itoh, K
Citation: M. Ito et al., Molecular basis of T cell-mediated recognition of pancreatic cancer cells, CANCER RES, 61(5), 2001, pp. 2038-2046
Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients
Authors: Suefuji, Y Sasatomi, T Shichijo, S Nakagawa, S Deguchi, H Koga, T Kameyama, T Itoh, K
Citation: Y. Suefuji et al., Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients, BR J CANC, 84(7), 2001, pp. 915-919
Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides
Authors: Murayama, K Kobayashi, T Imaizumi, T Matsunaga, K Kuramoto, T Shigemori, M Shichijo, S Itoh, K
Citation: K. Murayama et al., Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides, J IMMUNOTH, 23(5), 2000, pp. 511-518
Expression of tumor-rejection antigens in gynecologic cancers
Authors: Tanaka, S Tsuda, N Kawano, K Sakamoto, M Nishida, T Hashimoto, T Shichijo, S Kamura, T Itoh, K
Citation: S. Tanaka et al., Expression of tumor-rejection antigens in gynecologic cancers, JPN J CANC, 91(11), 2000, pp. 1177-1184
Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL
Authors: Nakao, M Shichijo, S Imaizumi, T Inoue, Y Matsunaga, K Yamada, A Kikuchi, M Tsuda, N Ohta, K Takamori, S Yamana, H Fujita, H Itoh, K
Citation: M. Nakao et al., Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL, J IMMUNOL, 164(5), 2000, pp. 2565-2574
Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes
Authors: Ito, M Shichijo, S Miyagi, Y Kobayashi, T Tsuda, N Yamada, A Saito, N Itoh, K
Citation: M. Ito et al., Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes, INT J CANC, 88(4), 2000, pp. 633-639
Expression of the SART1 tumor-rejection antigens in colorectal cancers
Authors: Sasatomi, T Yamana, H Shichijo, S Tanaka, S Okamura, T Ogata, Y Itoh, K Shirouzu, K
Citation: T. Sasatomi et al., Expression of the SART1 tumor-rejection antigens in colorectal cancers, DIS COL REC, 43(12), 2000, pp. 1754-1758
A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma
Authors: Nishizaka, S Gomi, S Harada, K Oizumi, K Itoh, K Shichijo, S
Citation: S. Nishizaka et al., A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma, CANCER RES, 60(17), 2000, pp. 4830-4837
Expression of the tumor-rejection antigen SART1 in brain tumors
Authors: Imaizumi, T Kuramoto, T Matsunaga, K Shichijo, S Yutani, S Shigemori, M Oizumi, K Itoh, K
Citation: T. Imaizumi et al., Expression of the tumor-rejection antigen SART1 in brain tumors, INT J CANC, 83(6), 1999, pp. 760-764
Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
Authors: Kikuchi, M Nakao, M Inoue, Y Matsunaga, K Shichijo, S Yamana, H Itoh, K
Citation: M. Kikuchi et al., Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes, INT J CANC, 81(3), 1999, pp. 459-466
Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients
Authors: Yang, D Nakao, M Shichijo, S Sasatomi, T Takasu, H Matsumoto, H Mori, K Hayashi, A Yamana, H Shirouzu, K Itoh, K
Citation: D. Yang et al., Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients, CANCER RES, 59(16), 1999, pp. 4056-4063
Expression of the SART-1 antigens in uterine cancers
Authors: Matsumoto, H Shichijo, S Kawano, K Nishida, T Sakamoto, M Itoh, K
Citation: H. Matsumoto et al., Expression of the SART-1 antigens in uterine cancers, JPN J CANC, 89(12), 1998, pp. 1292-1295
Risultati: 1-16 |